Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

NCT00071942 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

22

Enrollment

NIH

Sponsor class

Conditions

Male Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions

BIOLOGICAL: recombinant vaccinia-MUC1 vaccine
BIOLOGICAL: recombinant vaccinia-TRICOM vaccine
OTHER: laboratory biomarker analysis
PROCEDURE: quality-of-life assessment

Sponsor

National Cancer Institute (NCI)